Fernwood Investment Management, LLC Pliant Therapeutics, Inc. Transaction History

Fernwood Investment Management, LLC

$283 Million
Q4 2024

A detailed history of Fernwood Investment Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 425,424 shares of PLRX stock, worth $697,695. This represents 1.98% of its overall portfolio holdings.

Number of Shares

425,424

Previous 513,136 17.09%

Holding current value

$697,695

Previous $5.75 Million 2.61%

% of portfolio

1.98%

Previous 1.9%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$10.55 - $15.7 $925,361 - $1.38 Million	-87,712 Reduced 17.09%	425,424 $5.6 Million
Q3 2024 Oct 29, 2024	BUY	$10.52 - $14.35 $177,262 - $241,797	16,850 Added 3.4%	513,136 $5.75 Million
Q2 2024 Jul 31, 2024	BUY	$10.58 - $15.61 $506,792 - $747,734	47,901 Added 10.68%	496,286 $5.34 Million
Q1 2024 May 13, 2024	BUY	$14.14 - $19.59 $356,441 - $493,824	25,208 Added 5.96%	448,385 $6.68 Million
Q4 2023 Feb 05, 2024	BUY	$12.85 - $19.15 $558,653 - $832,546	43,475 Added 11.45%	423,177 $7.66 Million
Q3 2023 Nov 08, 2023	SELL	$14.58 - $20.15 $14,944 - $20,653	-1,025 Reduced 0.27%	379,702 $6.58 Million
Q2 2023 Aug 09, 2023	BUY	$18.12 - $30.56 $1.22 Million - $2.06 Million	67,479 Added 21.54%	380,727 $6.9 Million
Q1 2023 May 01, 2023	BUY	$18.73 - $36.26 $162,482 - $314,555	8,675 Added 2.85%	313,248 $8.33 Million
Q4 2022 Feb 07, 2023	BUY	$17.0 - $25.43 $1.39 Million - $2.08 Million	81,816 Added 36.73%	304,573 $5.89 Million
Q3 2022 Nov 09, 2022	BUY	$7.67 - $24.23 $80,895 - $255,553	10,547 Added 4.97%	222,757 $4.65 Million
Q2 2022 Aug 11, 2022	BUY	$4.11 - $8.75 $107,271 - $228,375	26,100 Added 14.02%	212,210 $1.7 Million
Q1 2022 May 03, 2022	BUY	$7.01 - $14.1 $83,068 - $167,085	11,850 Added 6.8%	186,110 $1.76 Million
Q4 2021 Feb 09, 2022	BUY	$12.27 - $18.26 $95,865 - $142,665	7,813 Added 4.69%	174,260 $2.35 Million
Q3 2021 Oct 28, 2021	BUY	$16.48 - $28.98 $252,737 - $444,437	15,336 Added 10.15%	166,447 $2.81 Million
Q2 2021 Aug 05, 2021	BUY	$28.05 - $37.69 $4.24 Million - $5.7 Million	151,111 New	151,111 $4.41 Million

Others Institutions Holding PLRX

# of Institutions

125

Shares Held

57.7M

Call Options Held

245K

Put Options Held

86.7K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $79.8M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.

Account

Fernwood Investment Management, LLC Pliant Therapeutics, Inc. Transaction History